Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Long-Term Prospects Are Getting Better for This IT Company

Page 1 of 2

If there is such a thing as a defensive growth stock in the IT sector, then Verint Systems Inc. (NASDAQ:VRNT) might be it. Along with its rival Nice Systems Ltd (ADR) (NASDAQ:NICE), Verint has put in a very consistent performance this year. Both companies are leaders in customer-interaction and analysis solutions, and both look set for good earnings growth in the future. Verint recently followed NICE in reaffirming its 2013 guidance, and those of you looking for a relatively safe option within tech should consider the stock carefully.

End demand looks good…
The market reacted well to Verint’s strong second-quarter results, even though it kept its full-year guidance unchanged. It was a similar story with NICE’s second-quarter results delivered earlier in the reporting season. While the market may appear to be overly rewarding these companies for merely hitting guidance, there are deeper reasons why it is right. Essentially, there are a number of positive trends in the sector that help increase their longer-term earnings potential.

  • Customers are demanding more value-added data-analytics solutions.
  • Big data is starting to be used across all kinds of data channels, and companies will need to capture and integrate data from things like call centers, websites, social media, video etc.
  • Verint and NICE have strong, installed bases with their hardware-capture solutions, and they have an opportunity to sell data analytics into them because customers value buying solutions from one vendor.
  • Companies can still generate growth — even in a weak economy — by better analyzing their existing customers.
  • Solutions to prevent money laundering, fraud, and other crime are seeing secular growth prospects because criminals are also using technology to become more sophisticated.
  •  Governments are increasingly pressured to use surveillance and intelligence gathering in order to monitor terrorist threats.

Verint Systems Inc. (NASDAQ:VRNT)The points above relate to end-market demand, but the type of demand is also likely to positively change their earnings potential.

That demand is likely to help Verint’s operating metrics
First, on its conference call, Verint predicted gross margins to be flat this year. You shouldn’t read too much into this, because longer-term, the prospects for margin expansion are significant. Increasing demand for higher-margin analytics solutions implies that gross margins should increase in the future. Quoting from the recent conference call:

So overall, we still have about 50-50 mix between capture products and analytics. But clearly, we are growing our analytics portfolio. Analytics is growing at higher growth rates, which kind of shifts the overall growth rate of the company.

Verint is benefiting from analytics, and NICE has the bonus of a deal with International Business Machines Corp. (NYSE:IBMthat integrates IBM’s analytics solutions within NICE’s solutions. This is a particular benefit to call centers and financials, sectors in which NICE is strong. IBM gets the benefit of tapping into NICE’s installed base, and the latter gets to offer its customers the kind of analytical solutions that they require in the “big-data” world. It’s a win-win scenario.

Second, even though it kept its full-year revenue-growth forecast at 6% to 7% and its EPS target at $2.75, the underlying picture did get better. Verint disclosed that it was seeing larger orders this year compared to last year.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!